A case of acute myeloid leukemia and multiple myeloma is observed to occur simultaneously

Shanfeng Hao1, Yingqi Li2, Huaquan Wang1

  • 1Department of Hematology, Tianjin Medical University General Hospital, Tianjin, People's Republic of China.

Medicine
|October 25, 2025
PubMed
Abstract

Insights

This rare case highlights the poor prognosis of simultaneous acute myeloid leukemia and multiple myeloma. Aggressive disease and complications led to a fatal outcome despite treatment.

Area of Science:

  • Hematology
  • Oncology

Background:

  • Simultaneous occurrence of acute myeloid leukemia and multiple myeloma is exceptionally rare, with only 31 cases reported globally.
  • Patients with these co-occurring hematologic malignancies face a very poor prognosis.
  • Prompt diagnosis and effective treatment are critical for improving outcomes.

Purpose of the Study:

  • To report a rare case of concurrent acute myeloid leukemia and multiple myeloma.
  • To discuss the diagnostic and therapeutic challenges associated with this dual diagnosis.
  • To emphasize the need for novel therapeutic strategies.

Main Methods:

  • A 68-year-old male presented with epistaxis, fever, and a neck mass.
  • Diagnosis involved morphology, immunophenotyping, histochemistry, and genetic testing, revealing high-risk acute monocytic leukemia with a TP53 mutation and multiple myeloma.
  • Treatment included azacitidine, hydrocortisone, and anti-infectious therapy.

Main Results:

  • The patient was diagnosed with high-risk acute monocytic leukemia and multiple myeloma.
  • Treatment was initiated with azacitidine and hydrocortisone.
  • A brain abscess developed during treatment, leading to the patient's demise two months post-hospitalization.

Conclusions:

  • The patient's disease was severe and rapidly progressive.
  • Comorbid severe infections and pancytopenia presented significant management challenges.
  • Further research into targeted therapies is crucial for this patient population.

Related Concept Videos

Disorders of Leukocytes01:27

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
1.8K
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.9K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
876
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K